Toronto’s CN Tower Lights Up Black & White!
November 10, 2018 - Toronto's CN Tower lights up black & white in honour of NET Cancer Awareness Day
November 10, 2018 - Toronto's CN Tower lights up black & white in honour of NET Cancer Awareness Day
Health Canada approves XERMELO™ (telotristat ethyl) for the treatment of adult patients suffering from refractory carcinoid syndrome diarrhea(1) "XERMELOTM is a novel, orally administered, inhibitor of the enzyme tryptophan hydroxylase [...]
The latest edition of the ePatient magazine has several articles that focus on Neuroendcorine Tumours (NETs). Check it out at: ePatient Magazine
Caprelsa (vandetanib) is indicated for the treatment of symptomatic or progressive Medullary thyroid cancer in adult patients with unresectable locally advanced or metastatic disease. Alberta Health Services has put the [...]
TELOTRISTAT is an adjunct to somatostatin analogue therapy for the long-term treatment of carcinoid syndrome to improve symptom control in adult patients with metastatic neuroendocrine tumours.The company who makes telotristat [...]
RESEARCH ARTICLE A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal Published in Modern Pathology [...]
RIP THE GREAT ARETHA FRANKLIN Aretha Franklin, the Queen of Soul, passed away from neuroendocrine cancer (NETs) of the pancreas, the very same cancer that killed Apple [...]
In March CNETS Canada reached out to the patient community through an online, anonymous survey to gather feedback and input on setting the research priorities for CNETS Canada sponsored grants [...]
REQUEST FOR PATIENT INPUT - TREATMENT WITH Lutetium-177 (177Lu)-DOTATATE (trade name Lutathera) Lutetium-177 (177Lu)-DOTATATE (trade name Lutathera), is a peptide receptor radionuclide therapy (PRRT) with radiolabeled somatostatin analogues (peptides). [...]
Une approche novatrice contre le cancer à l'Hôtel-Dieu de Québec « Une nouvelle approche médicale attire à Québec des Canadiens, et même des Américains, atteints d'une forme rare de cancer. Le traitement [...]